Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological prevention of gallstones after bariatric surgery
ChiCTR2400094215Phase 4Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cholelithiasis comparing Xiaoyan Lidan Tablets with UDCA (2 arms). Primary endpoint: Cholelithiasis formation rate. Started Dec 2024; status: completed.
02
Drugs
ursodeoxycholic acidXiaoyan Lidan
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on ChiCTR2400094215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094215.